This bill prohibits the import of eight specific minerals (including copper, nickel, palladium, and platinum) from Russia or Russian entities starting 90 days after enactment. It directly affects U.S. importers and businesses relying on these Russian-sourced minerals. The ban ends one year after the President certifies Russia has ceased hostilities against Ukraine, but resumes immediately if Russia restarts military action, with no presidential waivers allowed. The law remains in effect until a new certification confirms Russia's cessation of hostilities.
The Steel Modernization Act of 2024 provides financial assistance and tax credits to U.S. steel manufacturers adopting technologies that reduce greenhouse gas emissions from steel production. It requires recipients to produce "near-zero emissions intensity steel" by 2035, report emissions data, and implement community benefits plans that address local environmental and economic concerns. The bill also imposes a tariff on imported steel based on its emissions intensity, with revenues funding clean energy programs and administrative costs. This affects steel manufacturers, workers, and communities near steel facilities by promoting cleaner production while supporting domestic steel industry competitiveness.
The Patient Access Act of 2024 allows drug manufacturers to cover certain travel, lodging, and meal expenses for patients prescribed specialty drugs who live more than 1 hour driving distance (or 50 miles) from a treatment facility and have income below the median for their area. It permits manufacturers to pay for transportation, lodging near the facility, and meals during treatment periods, but only if patients aren’t already receiving these services for free from the facility and manufacturers don’t advertise the program before a prescription is issued. The bill also requires manufacturers to certify they won’t shift costs to Medicare or Medicaid and mandates a GAO study to track impacts on access, costs, and disparities for these patients. This applies specifically to patients needing transformative therapies like rare disease treatments, with the program starting January 1, 2025.
The Pharmacists Fight Back Act (HR 9096) sets new rules for Pharmacy Benefits Managers (PBMs) working with federal health care programs like Medicare Part D and Medicaid. It requires PBMs to reimburse in-network pharmacies at a rate covering the drug's actual cost plus a small fee (capped at $25), and to reduce patient cost-sharing by at least 80% of rebates received from drug manufacturers. The bill bans PBMs from steering patients to specific pharmacies, charging patients more than pharmacies are paid, or using rebates to lower pharmacy payments after claims are processed. It also mandates public reporting of drug pricing data to improve transparency, ensuring patients and pharmacies receive fairer treatment under federal health programs.
This bill creates temporary waivers for skilled nursing facilities and nursing facilities in areas with severe nurse aide shortages. It allows states to waive specific training and certification requirements for facilities located in designated shortage areas that haven't had recent quality-of-care deficiencies. Key provisions include extending the required nurse aide training period from 4 to 12 months, counting on-the-job hours toward training requirements, and offering flexibility in competency evaluations when state options are limited. The waivers apply to both Medicare and Medicaid-certified facilities meeting the defined shortage and quality criteria.
This bill requires Medicare Advantage plans to implement electronic prior authorization systems by 2027 and publish detailed data on their approval and denial rates for medical services by 2026. It directly affects Medicare Advantage plans (private insurers offering Medicare coverage) and their enrollees (seniors 65+), mandating transparency about prior authorization decisions, processing times, and appeal outcomes. Key provisions include requiring plans to report annual statistics on request approvals/denials, average processing times, and use of technology, with this data published publicly by the Centers for Medicare & Medicaid Services. The bill also sets timelines for plan responses to prior authorization requests and mandates reports to Congress on implementation and impacts.
The Essential Caregivers Act of 2024 requires nursing homes and similar facilities to allow residents to designate essential caregivers who provide emotional support or assistance with daily activities. During emergencies when regular visitation is restricted, facilities must permit at least one essential caregiver access to residents daily and cannot deny access without following specific procedures. Facilities may deny access for a maximum of 7 days during emergencies (or 14 days with state approval), and must provide a written explanation and appeal process if access is denied. The bill establishes a 48-hour appeal process for residents and caregivers to challenge denials, with facilities required to prove violations during appeals. This law applies to Medicare skilled nursing facilities, Medicaid nursing facilities, intermediate care facilities, and certain inpatient rehabilitation facilities.
HR 7836 would permanently remove import duties (taxes) on basketballs entering the United States. This bill directly affects businesses that import basketballs by eliminating the 30% tax they previously paid. The key mechanism is adding a new tariff classification (9506.62.70) to the US import rules, designating basketballs as duty-free. The change takes effect 15 days after the bill becomes law.
This bill requires Medicare to provide clear outreach and education so Medicare beneficiaries (enrolled in Part A, Part B, or Medicare Advantage plans) can authorize family caregivers to access their health information via 1-800-MEDICARE. It mandates the inclusion of a specific authorization form (CMS-10106) in Medicare notices and on Medicare.gov, along with training for call center staff. The Secretary must also share best practices to prevent fraud related to caregiver access and make materials available in non-English languages. It directly affects beneficiaries, their family caregivers, healthcare providers, and Medicare call center operators.
This bill changes the negotiation period for small-molecule drugs under the federal Drug Price Negotiation Program from 7 years to 11 years, matching the existing 11-year period for biologic drugs. It directly affects drug manufacturers participating in the program by extending the timeframe for price negotiations with the government. The amendment applies to all small-molecule drugs covered under the program, creating a uniform negotiation timeline for both drug types. The change takes effect as if included in the Inflation Reduction Act of 2022.
HR 7038, the Guaranteed Income for Foster Youth Act, creates a federal program providing automatic $12,000 annual cash benefits to former foster youth who exited care after age 16 but before age 27. Eligible youth aged 18-27 receive benefits for up to five years with no requirements to prove need, and states must enroll them automatically upon turning 18. Benefits are disregarded for other federal program eligibility, and states must offer financial literacy education while reporting detailed data on participants (including race, disability status, and housing). The program takes effect October 1, 2025, with states required to submit annual reports on outcomes.
This bill amends the Social Security Act to require states to establish child support obligations for the biological father of an unborn child when the mother requests it. Key provisions include allowing support to begin from the month of conception (as determined by a physician), permitting retroactive payments even if paternity is established after birth, and requiring court determination of payment amounts based on the mother's and child's best interests. It prohibits forced paternity testing for unborn children if it risks harm and explicitly bans any experimental programs from modifying these provisions. The bill directly affects mothers of unborn children and biological fathers, expanding child support enforcement to cover pregnancy.
